<unk><unk>  next-generation<unk>  (mNGS) is the comprehensive analysis of microbial and host genetic material (DNA or RNA) in<unk>  samples from patients. It uses the techniques of<unk> s to identify and characterize the genome of bacteria, fungi, parasites, and viruses without the need for a prior knowledge of a specific pathogen directly from<unk>  specimens. The capacity to detect all the potential pathogens in a sample makes<unk>  next generation<unk>  a potent tool in the diagnosis of infectious disease especially when other more directed assays, such as PCR, fail. Its limitations include<unk>  utility, laboratory validity, sense and sensitivity, cost and regulatory considerations. Outside of<unk>  medicine, similar work is done to identify genetic material in environmental samples, such as ponds or soil.
Clinical metagenomic sequencing
Molecular risk assessment
Functional molecular infection epidemiology
Multiplexed point-of-care testing
Point-of-care testing
Pharmacomicrobiomics
Whole genome sequencing
Microscopic Observation Drug Susceptibility assay